Atlas Trials

A Study of U-500 Insulin (LY041001) in Participants With Type 2 Diabetes

Clinical trial NCT02588950 · TERMINATED

Trial details

NCT number
NCT02588950
Sponsor
Eli Lilly and Company
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Diabetes Mellitus, Type 2
Start date
2016-01-12
Primary completion
2017-05-25
Enrollment
11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.